Nama Insights

Defiance Autism Impact ETF (ASD)

Health · Defiance ETFs LLC · NASDAQ

HealthETF
Defiance Autism Impact ETF (ASD) is an exchange-traded fund in the Health category. It has $1.35M in assets and an expense ratio of 0.79%. Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in Autism Impact Companies. The index is designed to measure the performance of publicly traded global companies in developed markets that provide products, services and/or research supporting the autism ecosystem comprised of individuals on the autism spectrum and within the broader neurodivergent community (“Autism Impact Companies”). It is non-diversified.
Assets under management$1.35M
Expense ratio0.79%
CategoryHealth
Dividend yield
NAV$27.18
Fund familyDefiance ETFs LLC
ExchangeNASDAQ

Top holdings

The largest positions Defiance Autism Impact ETF reports, by weight.

HoldingNameWeight
DFTX Definium Therapeutics Inc Ordinary Shares 3.95%
NEU.AX Neuren Pharmaceuticals Ltd 3.65%
LFST LifeStance Health Group Inc Ordinary Shares 3.44%
4578.T Otsuka Holdings Co Ltd 3.34%
RGEN Repligen Corp 3.26%
ACAD ACADIA Pharmaceuticals Inc 3.24%
RVTY Revvity Inc 3.04%
LHC.JO Life Healthcare Group Holdings Ltd 2.86%
BMY Bristol-Myers Squibb Co 2.81%
BMRN BioMarin Pharmaceutical Inc 2.81%

Other Health ETFs

Explore live ASD data on Nama Insights →